FDA inspection
Reprise Biomedical, Inc.: FDA inspection ending Nov 20, 2025
FDA inspection 1292234 · Voluntary Action Indicated (VAI) · Plymouth, MN
Key facts
| Inspection ID | 1292234 |
|---|---|
| Firm | Reprise Biomedical, Inc. |
| FEI number | 3010894343 |
| Address | 17400 Medina Rd Ste 100 |
| City | Plymouth |
| State | MN |
| ZIP | 55447 |
| Country | United States |
| Fiscal year | 2026 |
| Inspection end date | Nov 20, 2025 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Postmarket Assurance: Devices |
| Product type | Devices |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data